A 2-year, open-label pilot study of adjunctive chromium in patients with treatment-resistant rapid-cycling bipolar disorder.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/17224731
Conclusion of this study
Supplements analyzed in this study
|
Health conditions analyzed in this study
|
||
|
||
|
||
|
Functions related to this study
|
||
|
||
|
||
|
Body systems related to this study
 Nervous System |
